| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:1662.)
© 2003 American Heart Association, Inc.
Original Contributions |
From the Departments of Cerebrovascular Medicine (K.K., H.M., J.K., K.M., H.N.) and Radiology and Nuclear Medicine (N.Y., K.H.), National Cardiovascular Center, Osaka, Japan.
Reprint requests to Katsufumi Kajimoto, MD, Department of Cerebrovascular Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita City, Osaka 565-8565, Japan. E-mail kkajimot{at}hsp.ncvc.go.jp
Background and Purpose Perfusion-weighted magnetic resonance imaging (PWI) is a reliable and semiquantitative method for estimating cerebral hemodynamics. We sought to evaluate the potential of PWI for assessing cerebral blood flow (CBF) and metabolism compared with positron emission tomography (PET) in patients with chronic occlusive carotid disease.
Methods In 24 patients with chronic unilateral occlusive carotid disease, time-to-peak (TTP) delay (TTP-D) measured by PWI was compared with CBF, cerebral blood volume (CBV), and oxygen extraction fraction (OEF) obtained by PET. TTP indicates the time from the start of PWI to the bolus peak. TTP-D indicates the difference in TTP values between the occlusive and contralateral hemispheres. TTP-D was compared between patients with normal and reduced CBF/CBV and also between patients with normal and elevated OEF.
Results TTP-D in patients with reduced CBF/CBV was significantly longer than that in patients with normal CBF/CBV (3.4±1.8 versus 1.4±0.7 seconds; P<0.001). In the patients with reduced CBF/CBV, TTP-D correlated with OEF significantly (r=0.710, P<0.0001). TTP-D in patients with elevated OEF was significantly longer than that in patients with normal OEF (4.8±2.2 versus 2.0±0.9 seconds; P<0.01). In all 5 patients with TTP-D
4 seconds, OEF was elevated markedly.
Conclusions TTP-D
4 seconds is considered to indicate a high risk of hemodynamic failure. The measurement of TTP-D by PWI appears to provide important clinical information for evaluating cerebral hemodynamics in chronic occlusive carotid disease.
Key Words: carotid artery occlusion hemodynamics magnetic resonance imaging, perfusion-weighted tomography, emission computed
This article has been cited by other articles:
![]() |
O. Zaro-Weber, W. Moeller-Hartmann, W.-D. Heiss, and J. Sobesky The Performance of MRI-Based Cerebral Blood Flow Measurements in Acute and Subacute Stroke Compared With 15O-Water Positron Emission Tomography: Identification of Penumbral Flow Stroke, July 1, 2009; 40(7): 2413 - 2421. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanaka, E. Shimosegawa, K. Kajimoto, Y. Kimura, H. Kato, N. Oku, M. Hori, K. Kitagawa, and J. Hatazawa Chronic Middle Cerebral Artery Occlusion: A Hemodynamic and Metabolic Study with Positron-Emission Tomography AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1841 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takasawa, P. S. Jones, J. V. Guadagno, S. Christensen, T. D. Fryer, S. Harding, J. H. Gillard, G. B. Williams, F. I. Aigbirhio, E. A. Warburton, et al. How Reliable Is Perfusion MR in Acute Stroke?: Validation and Determination of the Penumbra Threshold Against Quantitative PET Stroke, March 1, 2008; 39(3): 870 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sobesky, O. Z. Weber, F.-G. Lehnhardt, V. Hesselmann, M. Neveling, A. Jacobs, and W.-D. Heiss Does the Mismatch Match the Penumbra?: Magnetic Resonance Imaging and Positron Emission Tomography in Early Ischemic Stroke Stroke, May 1, 2005; 36(5): 980 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sobesky, O. Z. Weber, F.-G. Lehnhardt, V. Hesselmann, A. Thiel, C. Dohmen, A. Jacobs, M. Neveling, and W.-D. Heiss Which Time-to-Peak Threshold Best Identifies Penumbral Flow?: A Comparison of Perfusion-Weighted Magnetic Resonance Imaging and Positron Emission Tomography in Acute Ischemic Stroke Stroke, December 1, 2004; 35(12): 2843 - 2847. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-D. Heiss, J. Sobesky, and V. Hesselmann Identifying Thresholds for Penumbra and Irreversible Tissue Damage Stroke, November 1, 2004; 35(11_suppl_1): 2671 - 2674. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |